Choice of initial antihypertensive drugs and persistence of drug use-a 4-year follow-up of 78,453 incident users
European Journal of Clinical Pharmacology,  Clinical Article

Selmer R et al. – Thiazides (TZs) and angiotensin II–receptor blockers (ARBs) were the most widely used first–line antihypertensives. Among the men enrolled in the study, ARB users had a somewhat better persistence with antihypertensive treatment than TZ users. Among both genders, continuation on ARBs was more common than continuation on TZs.

Methods
  • All initial users of antihypertensive drugs in 2005 and 2009 registered in the Norwegian Prescription Database were included.
  • Treatment on five index dates at 1–year intervals was recorded.
  • A patient was considered to be under treatment on an index date if a drug had been dispensed within the previous 180 days and to have maintained treatment persistence if he/she was on any antihypertensive treatment on the index date and all previous index dates.

Results
  • Among 78,453 new users of antihypertensives in 2005, women started more often with TZs than men (30 vs. 25 %) and less often with ARBs (22 vs. 25 %).
  • In men, the hazard of non–persistence with antihypertensive treatment was significantly lower among initial ARB users than among TZ users (hazard ratio 0.87, 95 % confidence interval 0.81–0.94); in women no significant difference was found.
  • After 4 years, 49 % of the men and 51 % of the women who had started with plain TZs were still using TZs, whereas 65 % of the male ARB users and 60 % of the female ARB users were still using ARBs.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Ophthalmology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Ophthalmology Articles

1 Mini-monovision versus multifocal intraocular lens implantation Journal of Cataract & Refractive Surgery, October 8, 2014    Clinical Article

2 Original and generic latanoprost for the treatment of glaucoma and ocular hypertension: are they really the same? Clinical and Experimental Pharmacology and Physiology, October 29, 2014    Clinical Article

3 Ganciclovir ophthalmic gel 0.15% for the treatment of acute herpetic keratitis: background, effectiveness, tolerability, safety, and future applications Full Text Therapeutics and Clinical Risk Management, September 10, 2014    Free full text    Clinical Article

4 Latanoprost in the treatment of glaucoma Full Text Clinical Ophthalmology, October 2, 2014    Free full text    Review Article

5 Age-related cataract in men in the selenium and vitamin E cancer prevention trial eye endpoints study: A randomized clinical trial JAMA Ophthalmology, October 3, 2014    Evidence Based Medicine    Clinical Article

6 The ocular hypotensive effect of saffron extract in primary open angle glaucoma: A pilot study Full Text BMC Complementary and Alternative Medicine, October 22, 2014    Free full text    Clinical Article

7 Effects of aspirin treatment on diabetic retinopathy. ETDRS report number 8. Early Treatment Diabetic Retinopathy Study Research Group Ophthalmology, August 4, 2014    Clinical Article

8 A randomized control trial to evaluate the effect of adjuvant selective laser trabeculoplasty versus medication alone in primary open-angle glaucoma: Preliminary results Full Text Clinical Ophthalmology, October 14, 2014    Free full text    Clinical Article

9 Femtosecond laser versus manual clear corneal incision in cataract surgery Journal of Refractive Surgery, September 2, 2014    Clinical Article

10 Comparison of 3 silicone hydrogel bandage soft contact lenses for pain control after photorefractive keratectomy Journal of Cataract & Refractive Surgery, October 7, 2014    Clinical Article

11 Comparative analysis of the visual performance after cataract surgery with implantation of a bifocal or trifocal diffractive IOL Journal of Refractive Surgery, October 27, 2014    Clinical Article

12 Ocular itch relief with alcaftadine 0.25% versus olopatadine 0.2% in allergic conjunctivitis: pooled analysis of two multicenter randomized clinical trials Advances in Therapy, October 20, 2014    Clinical Article

13 The novel Rho kinase (ROCK) inhibitor K-115: A new candidate drug for neuroprotective treatment in glaucoma Investigative Ophthalmology & Visual Science, October 10, 2014    Clinical Article

14 Cataractogenic potential of quetiapine versus risperidone in the long-term treatment of patients with schizophrenia or schizoaffective disorder: A randomized, open-label, ophthalmologist-masked, flexible-dose, non-inferiority trial Journal of Psychopharmacology, October 23, 2014    Clinical Article

15 Diabetes, fasting glucose, and the risk of glaucoma: A meta-analysis Ophthalmology, October 28, 2014    Evidence Based Medicine

16 A novel antiproliferative drug coating for glaucoma drainage devices Journal of Glaucoma, October 15, 2014    Clinical Article

17 Nepafenac 0.1% plus dexamethasone 0.1% versus dexamethasone alone: Effect on macular swelling after cataract surgery Journal of Cataract & Refractive Surgery, September 8, 2014    Clinical Article

18 Closure technique for leaking wound resulting from thermal injury during phacoemulsification Journal of Cataract & Refractive Surgery, September 4, 2014    Clinical Article

19 Long-term results of up to 12 years of over 700 cases of viscocanalostomy for open-angle glaucoma Acta Ophthalmologica, October 21, 2014    Clinical Article

20 Implementation of the posterior chamber intraocular lens intrascleral haptic fixation technique (glued intraocular lens) in a United States practice: Outcomes and insights Journal of Cataract & Refractive Surgery, October 30, 2014    Clinical Article

Indexed Journals in Ophthalmology: American Journal of Ophthalmology, Retina, Eye, Corneamore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close